Physician profile
David A Kuphal
NPI 1306971247
$1,620.22
in general payments reported to CMS, 2019-2025
7 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $300 · 2022: $470 · 2023: $200 · 2024: $262 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $850.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $881.58 | 2021-2025 | Tremfya, Simponi, Stelara |
| Dermavant Sciences, INC. | $173.56 | 2023-2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $140.92 | 2022-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $133.26 | 2021-2024 | Winlevi, Absorica Ld |
| Abbvie INC. | $131.75 | 2023-2025 | |
| Leo Pharma INC. | $116.46 | 2023-2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $42.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kuphal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.